CClinicalTrials.gg
CompletedNCT06079814Updated Aug 4, 2026

Virtual Reality Application for Pain and Anxiety Reduction During Cystoscopy

An interventional study of virtual reality intervention in Pain and Anxiety, sponsored by Cukurova University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-04.

Sponsored by Cukurova University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this research is to conduct a two-group randomized controlled intervention study to determine the effect of virtual reality applications on pain and anxiety during cystoscopy. The study population will consist of patients who have applied to the urology outpatient clinic of a University Hospital for cystoscopy. The study sample will be composed of patients who volunteer to participate in the study and meet the criteria during the planned dates of the research. Data will be collected using a 'Personal Information Form' created by the researcher through a literature review, the 'Visual Analog Scale' (VAS) for assessing pain, and the 'State Anxiety Inventory' (SAI) for assessing anxiety.

02

Conditions studied

  • Pain
  • Anxiety
03

In context

Pain

2,219 studies on the registry are indexed under Pain; 917 are open to participants now.

This study's enrollment of 65 is close to the median of 70 across 1,904 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Cukurova University is the lead sponsor of 247 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Being literate,
  • Being conscious,
  • Ability to understand and speak Turkish and not have hearing or visual impairment,
  • Agreeing to participate in the research.

Exclusion criteria

Exclusion Criteria:

  • Having a diagnosed psychiatric and mental illness,
  • Patients diagnosed with epilepsy (due to the risk of virtual reality glasses triggering epileptic seizures),
  • Patients who do not want to continue the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
65 participants (actual)

Study arms

  • Experimental
    experiment group

    Patients will wear virtual reality glasses 10 minutes before cystoscopy. The content chosen by the patient (there will be three options) will be watched throughout the procedure.

    Other: virtual reality intervention

  • No intervention
    control group

    Standard procedure.

Interventions

  • Othervirtual reality intervention

    Patients will be shown content through the patient's virtual reality glasses throughout the cystoscopy procedure.

06

What researchers measure

Primary outcomes

  1. The effect of virtual reality applications on pain during cystoscopy

    The patient's pain will be assessed using the 'Visual Analog Scale (VAS).' This scale involves marking on a 10 cm vertical or horizontal line, with one end indicating no pain at all and the other end indicating the most severe pain, to assess and measure the level of pain.

    Time frame: 30 minutes after the procedure

  2. The effect of virtual reality applications on anxiety during cystoscopy

    Procedure related anxiety will be assessed using the 'State Anxiety Inventory.' This inventory consists of a total of 20 items and the scoring ranges from 20 to 80 points. The higher the total score obtained from the scale, the higher the level of anxiety experienced by the individual is interpreted.

    Time frame: 30 minutes after the procedure

07

Study locations

1 site
  • Cukurova University
    Adana, 01030, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06079814
Lead sponsor
Cukurova University
Responsible party
Seyma Yurtseven (Clinic Nurse, Cukurova University) — Principal investigator
First posted
Oct 12, 2023
Start date
Oct 10, 2023
Primary completion
Sep 10, 2024
Completion
Oct 20, 2025
Last update
Aug 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion